DK1541137T3 - Transdermalt delivery system af gestoden - Google Patents

Transdermalt delivery system af gestoden

Info

Publication number
DK1541137T3
DK1541137T3 DK04078365.6T DK04078365T DK1541137T3 DK 1541137 T3 DK1541137 T3 DK 1541137T3 DK 04078365 T DK04078365 T DK 04078365T DK 1541137 T3 DK1541137 T3 DK 1541137T3
Authority
DK
Denmark
Prior art keywords
gestoden
delivery system
transdermal delivery
transdermal
delivery
Prior art date
Application number
DK04078365.6T
Other languages
English (en)
Inventor
Stefan Dr Bracht
Thomas Langguth
Michael Prof Dr Dittgen
Petra Huber
Drik Schenk
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1541137(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1541137T3 publication Critical patent/DK1541137T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04078365.6T 2003-12-12 2004-12-10 Transdermalt delivery system af gestoden DK1541137T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03078881 2003-12-12

Publications (1)

Publication Number Publication Date
DK1541137T3 true DK1541137T3 (da) 2010-04-26

Family

ID=34924031

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04078365.6T DK1541137T3 (da) 2003-12-12 2004-12-10 Transdermalt delivery system af gestoden
DK09173898.9T DK2138169T3 (da) 2003-12-12 2004-12-10 Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09173898.9T DK2138169T3 (da) 2003-12-12 2004-12-10 Transdermalt frigivelsessystem af hormoner uden penetrerings-fremmere

Country Status (23)

Country Link
EP (2) EP1541137B1 (da)
CN (1) CN101843603B (da)
AR (1) AR046762A1 (da)
AT (1) ATE457168T1 (da)
CR (1) CR8465A (da)
CY (2) CY1110637T1 (da)
DE (1) DE602004025444D1 (da)
DK (2) DK1541137T3 (da)
ES (2) ES2445690T3 (da)
GT (1) GT200400262A (da)
HN (1) HN2004000526A (da)
HR (2) HRP20100254T1 (da)
JO (1) JO2606B1 (da)
ME (1) ME01069B (da)
MY (2) MY144053A (da)
PE (1) PE20051035A1 (da)
PL (2) PL1541137T3 (da)
PT (2) PT2138169E (da)
RS (2) RS51260B (da)
SI (2) SI2138169T1 (da)
SV (1) SV2006001970A (da)
TW (1) TWI257299B (da)
UA (1) UA89766C2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073696A1 (de) 2003-02-21 2004-09-02 Schering Ag Uv-stabiles transdermales pflaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
WO2010042610A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
WO2010042607A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc Transdermal delivery
WO2010042612A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (en) * 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
SI2613772T1 (sl) 2010-09-06 2017-03-31 Bayer Intellectual Property Gmbh Transdermalni obliži z nizkim odmerkom z visoko stopnjo sproščanja zdravila
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
HK1204287A1 (en) * 2012-01-27 2015-11-13 敏捷治疗公司 Transdermal hormone delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
HU210549B (en) * 1988-10-27 1995-05-29 Schering Ag Process for producing transdermally applicable pharmaceutical composition containing gestodene
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
MX9101787A (es) 1990-10-29 1992-06-05 Alza Corp Formulaciones,metodos y dispositivos anticonceptivos transdermicos
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
KR100758757B1 (ko) 1999-11-24 2007-09-14 애자일 쎄라퓨틱스, 인크. 개량된 경피적 피임제 송달시스템 및 송달방법
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US20020106402A1 (en) 2000-12-05 2002-08-08 Hartwig Rod Lawson Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

Also Published As

Publication number Publication date
EP2138169B1 (en) 2013-11-06
CN101843603A (zh) 2010-09-29
CN101843603B (zh) 2012-06-27
PL2138169T3 (pl) 2014-04-30
ATE457168T1 (de) 2010-02-15
RS51260B (sr) 2010-12-31
JO2606B1 (en) 2011-11-01
RS53182B (sr) 2014-06-30
UA89766C2 (en) 2010-03-10
EP1541137A3 (en) 2005-11-16
DE602004025444D1 (de) 2010-03-25
HK1074801A1 (en) 2005-11-25
AR046762A1 (es) 2005-12-21
SV2006001970A (es) 2006-02-16
DK2138169T3 (da) 2013-11-18
CR8465A (es) 2007-06-06
PL1541137T3 (pl) 2010-07-30
SI1541137T1 (sl) 2010-06-30
SI2138169T1 (sl) 2014-03-31
EP1541137A2 (en) 2005-06-15
PT2138169E (pt) 2014-02-17
TWI257299B (en) 2006-07-01
EP1541137B1 (en) 2010-02-10
HRP20100254T1 (hr) 2010-06-30
ES2340925T3 (es) 2010-06-11
HRP20140077T1 (hr) 2014-02-28
CY1110637T1 (el) 2015-04-29
HK1132682A1 (en) 2010-03-05
ME01069B (me) 2012-10-20
CY1115064T1 (el) 2016-12-14
MY144053A (en) 2011-08-15
EP2138169A2 (en) 2009-12-30
TW200528073A (en) 2005-09-01
PT1541137E (pt) 2010-05-17
EP2138169A3 (en) 2011-04-06
MY152750A (en) 2014-11-28
PE20051035A1 (es) 2006-02-08
HN2004000526A (es) 2010-02-01
GT200400262A (es) 2005-10-31
ES2445690T3 (es) 2014-03-04

Similar Documents

Publication Publication Date Title
DK1599186T3 (da) System til administration af transmukalt lægemiddel
DK2609947T3 (da) Plasterlignende infusionsapparat
DK1481652T3 (da) Linseafgivelsessystem
DE602004017700D1 (de) Transmukosen verabreichung
ITMI20041123A1 (it) Fissaggio
DK1667992T3 (da) Quinazolinderivater
DE602004022101D1 (de) solches system
SE0302061L (sv) Tandsystem
EP1661594A4 (en) SYRINGE
ATE333271T1 (de) Uv-stabiles transdermales pflaster
AT500095B8 (de) Transdermales abgabesystem
DE602004011999D1 (de) Mehrbenutzer-übertragungssystem
DE112004001296D2 (de) Komponententräger
DK1544379T3 (da) Klemindretning
DK1541137T3 (da) Transdermalt delivery system af gestoden
SE0301097L (sv) Lokaliseringssystem
DE602004006752D1 (de) Autofokussystem
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
DK1689338T3 (da) Antimikrobielt klæbesystem
DK1769359T3 (da) Publikationsdata-verifikationssystem
DE602005020393D1 (de) Adhäsive Pflaster
DK1630468T3 (da) Pumpesystem
FI6455U1 (fi) Virtuaali-ikkunajärjestelmä
DK1592417T3 (da) Kombinationen af antidiabetiske lægemidler
FI20021817A0 (fi) Kanyyli